Posts

Showing posts with the label Salivary Gland Carcinoma (SGC) competitive landscape

Salivary Gland Carcinoma (SGC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Salivary gland malignancies are rare tumors that comprise multiple histologic entities with diverse clinical behavior. Mucoepidermoid carcinoma is the most frequent primary salivary malignancy that involves the parotid gland, followed by the submandibular and sublingual glands. The variation in histology and, in some cases, grade of malignancy may contribute to diversity in clinical behavior and prognosis of salivary gland malignancies. Although most salivary malignancies are asymptomatic, presentation with a rapidly enlarging mass may be accompanied by pain, functional neurologic deficits, soft-tissue invasion, or nodal enlargement. Primary salivary gland malignancies comprise a group of up to 20 distinct histopathologic entities present as an asymptomatic mass. However, some patients may experience rapid enlargement of the mass, soft tissue invasion, trismus, progressive loss of nerve function, pain, paresthesia, or development of enlarged neck nodes. ·    ...

Salivary Gland Carcinoma (SGC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Salivary gland malignancies are rare tumors that comprise multiple histologic entities with diverse clinical behavior. Mucoepidermoid carcinoma is the most frequent primary salivary malignancy that involves the parotid gland, followed by the submandibular and sublingual glands. The variation in histology and, in some cases, grade of malignancy may contribute to diversity in clinical behavior and prognosis of salivary gland malignancies. Although most salivary malignancies are asymptomatic, presentation with a rapidly enlarging mass may be accompanied by pain, functional neurologic deficits, soft-tissue invasion, or nodal enlargement. Primary salivary gland malignancies comprise a group of up to 20 distinct histopathologic entities present as an asymptomatic mass. However, some patients may experience rapid enlargement of the mass, soft tissue invasion, trismus, progressive loss of nerve function, pain, paresthesia, or development of enlarged neck nodes. ·    ...